Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesis

Andrew M Schumacher1, Anastasia V Velentza, D Martin Watterson

  • 1Center for Drug Discovery and Chemical Biology, Northwestern University, 303 East Chicago Avenue, W-896, Chicago, Illinois 60611, USA.

Biochemistry
|November 8, 2006
PubMed

Insights

Death-associated protein kinase (DAPK) phosphorylates ribosomal protein S6, revealing a novel mechanism for regulating protein synthesis and offering new therapeutic targets for neurodegenerative disorders.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Biochemistry

Background:

  • Death-associated protein kinase (DAPK) is a key regulator of apoptosis and a potential therapeutic target for neurodegenerative diseases.
  • The precise physiological substrates and functions of DAPK in neuronal cells are not fully understood.

Purpose of the Study:

  • To identify endogenous substrates of DAPK.
  • To investigate the role of DAPK in protein synthesis regulation.

Main Methods:

  • Immunoprecipitation assays to detect DAPK-S6 association in rat brain.
  • In vitro kinase assays using purified 40S ribosomal subunits.
  • Translation assays in rabbit reticulocyte lysate and neuroblastoma cells.

Main Results:

  • Mammalian 40S ribosomal protein S6 was identified as a direct substrate of DAPK.
  • DAPK selectively phosphorylates S6 at serine 235.
  • DAPK-mediated S6 phosphorylation correlates with the suppression of protein synthesis.

Conclusions:

  • DAPK acts as an S6 kinase, directly phosphorylating S6 at serine 235.
  • DAPK plays a novel role in regulating translation, potentially through S6 phosphorylation.
  • This discovery provides new insights into DAPK's function in neuronal pathophysiology and disease treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...